Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Editorial comment on: Expression of aquaporin 1 in primary renal tumors: a prognostic indicator of clear-cell renal cell carcinoma.

Rentsch CA, Bachmann A.

Eur Urol. 2009 Oct;56(4):699. doi: 10.1016/j.eururo.2008.10.015. Epub 2008 Oct 14. No abstract available.

PMID:
18930584
2.

Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.

Huang Y, Murakami T, Sano F, Kondo K, Nakaigawa N, Kishida T, Kubota Y, Nagashima Y, Yao M.

Eur Urol. 2009 Oct;56(4):690-8. doi: 10.1016/j.eururo.2008.10.014. Epub 2008 Oct 14.

PMID:
18930582
3.

Editorial comment on: Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.

Staehler M.

Eur Urol. 2009 Mar;55(3):678. doi: 10.1016/j.eururo.2008.04.002. Epub 2008 Apr 9. No abstract available.

PMID:
18450364
4.

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.

Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.

J Urol. 2009 Nov;182(5):2144-9. doi: 10.1016/j.juro.2009.07.015. Epub 2009 Sep 15.

PMID:
19758660
5.

Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.

Meyer HA, Tölle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K, Kristiansen G.

Eur Urol. 2009 Mar;55(3):669-78. doi: 10.1016/j.eururo.2008.04.001. Epub 2008 Apr 9.

PMID:
18450365
6.

Water channel protein subtype suggests the origin of renal cell carcinoma.

Kageyama Y, Sasaki S, Yamamura Y, Oshima H, Ikawa Y.

J Urol. 1996 Jul;156(1):291-5.

PMID:
8648826
7.

Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.

Fritzsche FR, Oelrich B, Johannsen M, Kristiansen I, Moch H, Jung K, Kristiansen G.

Clin Cancer Res. 2008 Nov 1;14(21):7035-42. doi: 10.1158/1078-0432.CCR-08-0855.

8.

Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.

Kempkensteffen C, Hinz S, Christoph F, Krause H, Magheli A, Schrader M, Schostak M, Miller K, Weikert S.

J Cancer Res Clin Oncol. 2008 May;134(5):543-50. Epub 2007 Oct 9.

PMID:
17922292
9.

Cellular B-2 microglobulin expression as a prognostic indicator in renal cell carcinoma.

Levin I, Kuperman O, Goldstein J, Neumann L, Segal S, Kaneti J, Lismer L, Machpud A, Klein B.

Acta Oncol. 1991;30(8):941-5.

PMID:
1777246
10.

Bone morphogenetic protein-7 expression is down-regulated in human clear cell renal carcinoma.

Basic-Jukic N, Hudolin T, Radic-Antolic M, Coric M, Zadro R, Kastelan Z, Pasini J, Bandic-Pavlovic D, Kes P.

J Nephrol. 2011 Jan-Feb;24(1):91-7.

PMID:
20540029
11.

Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.

Lee CT, Genega EM, Hutchinson B, Fearn PA, Kattan MW, Russo P, Reuter VE.

Urol Oncol. 2003 May-Jun;21(3):179-84.

PMID:
12810203
12.

The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.

Elsamman EM, Fukumori T, Tanimoto S, Nakanishi R, Takahashi M, Toida K, Kanayama HO.

BJU Int. 2006 Sep;98(3):668-73.

13.

Editorial comment on: inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome.

Axelson H, Johansson M.

Eur Urol. 2010 May;57(5):866. doi: 10.1016/j.eururo.2009.08.017. Epub 2009 Aug 27. No abstract available.

PMID:
19747759
14.

Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival.

Nanus DM, Schmitz-Dräger BJ, Motzer RJ, Lee AC, Vlamis V, Cordon-Cardo C, Albino AP, Reuter VE.

J Natl Cancer Inst. 1993 Oct 6;85(19):1597-9. No abstract available.

PMID:
8411233
15.

Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma.

Lee HJ, Kim DI, Kang GH, Kwak C, Ku JH, Moon KC.

Urology. 2009 Feb;73(2):394-9. doi: 10.1016/j.urology.2008.08.472. Epub 2008 Oct 11.

PMID:
18849062
16.

CD44 is an independent prognostic factor in conventional renal cell carcinomas.

Paradis V, Ferlicot S, Ghannam E, Zeimoura L, Blanchet P, Eschwége P, Jardin A, Benoît G, Bedossa P.

J Urol. 1999 Jun;161(6):1984-7.

PMID:
10332486
17.

Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma.

Vartanian AA, Stepanova EV, Gutorov SL, Solomko ESh, Grigorieva IN, Sokolova IN, Baryshnikov AY, Lichinitser MR.

Can J Urol. 2009 Aug;16(4):4726-32.

PMID:
19671223
18.

Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.

Bamias A, Chorti M, Deliveliotis C, Trakas N, Skolarikos A, Protogerou B, Legaki S, Tsakalou G, Tamvakis N, Dimopoulos MA.

Urology. 2003 Aug;62(2):368-73.

PMID:
12893366
19.

Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival.

Merseburger AS, Kramer MW, Hennenlotter J, Serth J, Kruck S, Gracia A, Stenzl A, Kuczyk MA.

World J Urol. 2008 Dec;26(6):637-42. doi: 10.1007/s00345-008-0294-8. Epub 2008 Jul 2.

PMID:
18594826
20.

The diagnostic and prognostic utility of claudin expression in renal cell neoplasms.

Lechpammer M, Resnick MB, Sabo E, Yakirevich E, Greaves WO, Sciandra KT, Tavares R, Noble LC, DeLellis RA, Wang LJ.

Mod Pathol. 2008 Nov;21(11):1320-9. doi: 10.1038/modpathol.2008.116. Epub 2008 Jun 27. Erratum in: Mod Pathol. 2009 Feb;22(2):321.

Supplemental Content

Support Center